Qianghua Zhou

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Factors

Top Venues

Leukemia & lymphoma

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Qianghua Zhou, Davidson Zhao, Morjgan Zarif, Marta B Davidson, Mark D Minden, Anne Tierens, Yu Wing Tony Yeung, Cuihong Wei, Hong Chang
Real-World Analysis of Clinical Outcomes in AML, Myelodysplasia-Related: a Comparison of ICC and WHO-HAEM5 Criteria. Blood advances (2024)
Qianghua Zhou, Davidson Zhao, Mojgan Zarif, Marta B Davidson, Mark D Minden, Anne Tierens, Yu Wing Tony Yeung, Cuihong Wei, Hong Chang
A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria. Blood advances 8 (7) (2024)
Dan-Ni Yang, Cheng Yan, Li Yan, Yan Niu, Jian-Xun Wen, Ling Hai, Wen-Hui Gao, Ying-Jun Wang, Ya-Fei Wang, Qianghua Zhou, Wen-Qi Zheng, Zhi-Cheng Zhang
Apolipoprotein E in patients with undiagnosed pleural effusion: a prospective diagnostic test accuracy study. Expert review of respiratory medicine (2024)
Qianghua Zhou, Davidson Zhao, Mojgan Zarif, Marta B Davidson, Mark D Minden, Anne Tierens, Yu Wing Tony Yeung, Cuihong Wei, Hong Chang
A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria. Blood advances 8 (7) (2024)
Davidson Zhao, Mojgan Zarif, Qianghua Zhou, José-Mario Capo-Chichi, Andre Schuh, Mark D Minden, Atenafu G Eshetu, Rajat Kumar, Hong Chang
TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation. Cancers 15 (12) (2023)
Davidson Zhao, Mojgan Zarif, Qianghua Zhou, José-Mario Capo-Chichi, Andre Schuh, Mark D Minden, Atenafu G Eshetu, Rajat Kumar, Hong Chang
TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation. Cancers 15 (12) (2023)
Inna Y Gong, Mahmood Aminilari, Ivan Landego, Katrina Hueniken, Qianghua Zhou, John G Kuruvilla, David C Hodgson
Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials. Leukemia & lymphoma (2023)
Qianghua Zhou, Davidson Zhao, Mojgan Zarif, Yu Wing Tony Yeung, Guillaume Richard Carpentier, Hong Chang
Impact of secondary-type mutations in NPM1 mutated AML. European journal of haematology (2023)